Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: J Heart Lung Transplant. 2022 Feb 3;41(6):840–848. doi: 10.1016/j.healun.2022.01.1377

Table 1.

Demographics and Clinical Features of CTOT03 Heart Transplant Participants

Patients without ACR Recipients with 2R EMBs
Number of patients 19 7
Donors
Age (Median[IQR]) 37 (21 - 52) 21 (16 - 32)
Gender (Male n, %) 16 (84%) 6 (85%)
Race
African American (n, %) 2 (11%) 0 (0%)
White (n, %) 16(84%) 5 (71%)
Unknown (n, %) 1 (5%) 2 (29%)
Recipients
Age (Median[IQR]) 60 (53 - 61) 56 (46 - 58)
Gender (Male n, %) 16 (84%) 5 (71%)
Indications for Heart Transplant
Idiopathic 2 (11%) 3 (43%)
Ischemic 13 (68%) 2 (29%)
Other 4 (21%) 2 (29%)
Ancestry
African American (n, %) 2 (11%) 1 (14%)
White (n, %) 16(84%) 5(71%)
Unknown (n, %) 1 (5%) 1 (14%)
    Study site (HUP, n, %) 12 (63%) 3 (43%)
Time to 1st ACR (>=2R)(Median[IQR]) NA 58 [9 - 165]